2-((2E,6E,10E,14E,18E,22E)-3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaen-1-yl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione;CoQ7; UQ7; (all-E)-2-(3,7,11,15,19,23,27-Heptamethyl-2,6,10,14,18,22,26-octacosaheptaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone; Ubiquinone 35; Ubiquinone 7; Ubiquinone Q7; (all-E)-2-(3,7,11,15,19,23,27-Heptamethyl-2,6,10,14,18,22,26-octacosaheptaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione;trans-Coenzyme Q7;
Ubidecarenone (Coenzyme Q10) EP Impurity B is a fully characterized chemical compound used as a reference standard of API Coenzyme. The standard offered is compliant with regulatory guidelines. Ubidecarenone (Coenzyme Q10) EP Impurity B is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 303-95-7
